tnucos
immun
system
mammal
consist
aq
integr
network
lymphoid
cell
wbich
work
concert
innat
host
factor
promot
host
defens
major
mucos
effector
immun
mechan
includ
secretori
antibodi
larg
immunoglobulin
iga
isotyp
cytotox
cell
well
cytokin
chemokin
receptor
immiinolog
unrespons
toler
key
featur
mucos
immun
system
deliber
vaccin
natur
immun
mucos
rout
effect
induc
immun
suppress
divers
compart
locat
aerodigest
genitourinari
tract
exocrin
gland
commun
via
preferenti
home
lymphocyt
antigenpres
cell
mucos
administr
antigen
may
resuh
tbe
concomit
express
secretori
immunoglobulin
siga
antibodi
respons
variou
mucos
tissu
secret
certain
condit
suppress
immun
respons
thu
develop
formul
base
effici
deliveri
select
antigenstolero
gen
cytokin
adjuv
may
impact
design
futur
vaccin
specif
immunotberapeut
approach
diseas
associ
untoward
immun
respons
sucb
autoimmun
disord
allerg
reaction
tissuedamag
inflammatori
reaction
trigger
persist
microorgan
mucou
membran
cover
aerodigest
urogenit
tract
well
eye
conjunctiva
inner
ear
duct
exocrin
gland
endow
power
mechan
physicochem
cleans
mechan
degrad
repel
foreign
matter
addit
larg
highli
special
immun
system
protect
surfac
therebi
also
tbe
bodi
interior
potenti
insult
environ
healthi
human
adult
local
immun
system
contribut
almost
immunocyt
cell
accumul
transit
variou
mucos
organ
gland
togeth
form
tbe
mucosaassoci
lymphoid
tissu
malt
largest
mammalian
lymphoid
organ
system
malt
three
main
function
protect
mucou
membran
colon
invas
potenti
danger
microb
encount
prevent
uptak
undegrad
antigen
includ
foreign
protein
deriv
ingest
food
commens
microorgan
prevent
develop
harm
immun
respons
antigen
reach
bodi
interior
varianc
tbe
system
immun
apparatu
function
normal
steril
milieu
often
respond
vigor
invad
malt
guard
organ
replet
foreign
matter
follow
upon
encount
plethora
anligen
stimuli
tbe
malt
must
ignor
antigen
econom
select
appropri
effector
mechan
regul
intens
avoid
bystand
tissu
damag
immunolog
exhaust
sinc
system
discrimin
pathogen
microorgan
one
hand
innocu
matter
dietari
matter
commens
microorgan
tbe
like
recogn
foreign
peptid
elucid
mechan
determin
whether
recognit
divers
antigen
result
activ
immun
immun
suppress
ignor
major
impact
develop
effect
mucos
vaccin
infecti
inflammatori
diseas
although
immun
apparatu
remark
divers
strong
evid
certain
type
immun
respons
take
place
basic
restrict
certain
anatom
locat
witbin
tbe
bodi
malt
repres
wellknown
exampl
compartment
immunolog
system
oppos
tbe
central
peripher
lymphoid
organ
malt
contain
inhomogen
distribut
b
cell
whose
phenotyp
repertoir
development
origin
secret
product
henc
probabl
also
function
differ
first
prime
immunoglobulin
isotyp
produc
assembl
mucos
tissu
secretori
immunoglobulin
iga
present
trace
amount
intravascular
compart
although
major
speci
differ
observ
nonconvent
lymphocyt
rare
seen
spleen
peripher
lymph
node
encount
appreci
frequenc
differ
mucos
locat
eg
ap
pand
ys
pt
cell
gut
epithelium
antigen
receptor
repertoir
also
differ
locat
tbu
selfreact
cell
detect
among
murin
intestin
intraepitheli
ai
tcr
lymphocyt
furthermor
contrast
b
lymphocyt
found
central
peripher
lymphoid
organ
certain
ap
cell
found
mucosa
presum
also
mucos
b
cell
depend
thymn
bone
marrow
develop
respect
addit
diverg
lineag
driven
differ
organ
tissuespecif
home
receptor
local
select
mechan
may
import
diversif
mucos
immun
respons
select
may
exert
local
antigen
antigenpres
cell
apc
whose
function
vari
anatom
locat
cytokin
chemokin
cellmatrix
interact
thu
lead
expans
mainten
clone
wherea
other
dilut
delet
thu
cellular
composit
compartment
affer
effer
limb
malt
function
essenti
independ
system
immun
apparatu
although
infecti
microorgan
colon
enter
host
mucos
membran
system
immun
system
tbe
focu
vaccin
research
asid
eas
administr
import
advantag
mucos
vaccin
theoret
possibl
induc
mucos
system
immun
respons
revers
hold
true
sinc
specif
humor
immun
defens
provid
serum
hy
secretori
antibodi
predomin
iga
isotyp
tbat
select
transport
extern
secret
vaccin
consid
improv
develop
ideal
induc
system
mucos
respons
equal
import
host
immun
defens
capac
malt
promot
specif
immunolog
unrespons
toler
natur
deliber
mucos
exposur
varieti
antigen
form
toler
consid
major
adapt
immun
defens
mechan
wherebi
avoid
develop
harm
immun
respons
plethora
dietari
airborn
antigen
encount
day
thu
theoret
standpoint
possibl
manipul
mucos
immun
system
toward
posit
immun
andor
toler
appear
extrem
attract
consid
strategi
aim
protect
host
colon
invas
microbi
pathogen
also
prevent
andor
modul
develop
potenti
harm
immunolog
reaction
pathogen
also
certain
self
antigen
allergen
consider
final
bring
mucos
vaccin
center
stage
vaccin
develop
adapt
effector
mechan
mucosa
immun
defens
three
major
adapt
effector
mechan
particip
immun
defens
mucos
surfac
secretori
antibodi
format
antigenspecif
cellmedi
cytotox
primari
mechan
involv
antimicrobi
defens
act
primarili
exclus
epitbellutn
mucos
tissu
addit
third
form
mucos
immun
defens
contribut
regulatori
cell
wbich
act
epithelium
submucosa
well
extramucosai
tissu
mainli
tbe
product
solubl
mediat
although
cell
may
regul
iga
anfibodi
format
develop
cellmedi
cytotox
respons
tbey
particip
maintain
mucos
toler
environment
matter
regard
key
player
mucos
defens
inflamm
immun
respons
express
mucos
tissu
typifi
secretori
immunoglobulin
siga
antibodi
siga
constitut
predomin
ig
class
human
externa
secret
best
known
entiti
provid
specif
immun
protect
mucosa
tissu
whi
e
tbe
syntliesi
assemuy
j
chaincontain
po
ymeric
iga
mo
ecu
es
contribut
p
asma
ce
ls
mucos
epitb
ia
ce
synthes
secretori
compon
whic
act
ce
surfac
receptor
faci
itat
transport
new
form
iga
across
epith
ia
ce
tbe
resist
siga
endogen
proteas
make
antibodi
isotyp
uniqu
suit
protect
mucos
surfac
siga
antibodi
provid
immun
exclus
bacteri
viral
pathogen
bacteria
toxin
otber
potenti
harmfu
mo
ecu
es
function
appear
faciht
affin
bind
mucu
siga
report
neutra
ize
directli
number
virus
mediat
antibodydepend
cellmedi
cytotox
interfer
util
growth
factor
bacteri
pathogen
mucos
environ
mucos
deriv
siga
differ
bone
marrowderiv
serum
iga
term
specif
antibodi
activ
also
proport
polymer
vs
tnonomer
form
ontogeni
mucos
system
iga
compart
display
characterisf
appar
independ
pattern
matur
adult
level
siga
reach
extern
secret
consider
earlier
month
year
serum
adolesc
experi
tbat
address
tbe
origin
mucos
antibodi
indic
overwhelm
proport
antibodi
produc
local
mucos
tissu
minor
fraction
deriv
tbe
circul
speci
includ
human
although
tbe
focu
investig
mucos
cytotox
lymphocyt
ctl
induc
virus
born
mind
antibodymedi
cytotox
natur
killer
nk
cell
activ
major
respons
associ
mucos
lymphocyt
evanc
latter
respons
field
mucos
vaccin
develop
ascertain
therefor
beyond
scope
review
two
major
effector
mechan
associ
ctl
describ
exocytosi
ctl
onto
target
cell
granul
contain
poreform
protein
perforin
sever
serin
proteas
also
term
granzym
ligat
tumor
necrosi
factor
tnf
receptorlik
molecul
fa
target
cell
fasl
tnf
ctl
side
earli
sudi
demonstr
intraperiton
immun
allogen
tumour
induc
specif
ctl
gut
lamina
propria
epithelium
time
cytotox
lymphocyt
could
detect
peripber
lymphoid
organ
estabhsh
administr
certain
enter
ctl
ihe
gcniiol
tract
mucoso
rhesu
macaqu
model
vagina
infect
simian
immunodefici
viru
siv
usefu
studi
local
immun
siv
femal
reproduct
aact
recent
studi
mode
provid
direct
evid
pctl
occur
femal
macaqu
reproduct
tissu
infect
siv
induc
effector
ctl
respons
vagin
mucosa
interestingli
macaqu
vagin
infect
siyhivl
cliimer
viru
shiv
display
gagspecif
ctl
peripher
blood
resist
two
challeng
virul
siv
recent
studi
involv
infect
women
cervic
tcell
line
establish
cytobrush
specimen
shown
lyse
autolog
target
express
protein
class
th
cell
differenti
respons
foreign
antigen
produc
distinct
cytokin
array
naiv
pth
cell
first
produc
interleukin
il
develop
cell
produc
multipl
cytokin
includ
stage
often
term
tho
tissu
microenviron
cytokin
milieu
natur
antigen
influenc
differenti
tho
ce
thu
infect
intracellular
bacteria
ead
ie
format
th
ce
ce
often
deve
op
fo
owe
product
activ
macrophag
exogen
antigen
mucosa
microenviron
trigger
cell
produc
initi
respons
tho
cell
cell
also
produc
expans
subset
well
array
may
includ
product
howev
reader
appreci
individu
cytokin
regul
differ
signal
transduct
pathway
tbat
thl
cell
produc
entir
array
array
cytokin
import
bcell
isotyp
switch
support
iggl
ige
iga
respons
mous
system
thl
cell
also
sensit
crossregul
exampl
ifni
produc
th
cell
inhibit
prolifer
cell
caus
isotyp
switch
igm
inhibit
isotyp
switch
induc
convers
cell
regul
effect
thl
cell
secret
turn
inhibit
thl
cell
secret
cytokin
thu
decreas
ifnymedi
inhibit
cell
bulk
availab
e
evid
mice
suggest
mucosa
tissu
favor
tbe
develop
respons
situat
clearcut
human
thu
freshli
isol
human
lamina
propria
cel
contain
exceptiona
high
frequenc
ifnyproduc
ce
compar
ceu
produc
furthermor
even
mice
infect
recombin
salmondla
ead
format
thl
ceu
ce
peyer
patch
iand
induct
iga
product
protein
antigen
highli
depend
helper
cell
human
tgfp
concert
shown
promot
bce
differenti
igaproduc
ce
regard
appear
addit
resid
ceu
produc
arg
amount
transform
growth
factor
tgf
p
human
epithelia
ce
intestina
origin
provid
major
sourc
tgfp
unpublish
observ
ii
suggest
cooper
neig
ibor
lymphocyt
epit
ie
ial
ce
mucosa
microenviron
pivota
promot
se
ectiv
transport
new
form
iga
across
epith
ia
program
preferentia
matur
igacommit
b
ce
final
addit
type
regulatori
cell
clone
tbe
mesenter
lymph
node
rodent
fed
repeatedli
wit
antigen
ies
ce
cell
produc
tgfp
variabl
amount
appear
exert
downregu
atori
properti
thl
ce
sinc
tgfp
happen
serv
switch
factor
murin
human
iga
appear
p
ay
major
ro
e
mucosa
eranc
review
ce
may
import
function
mucosa
homeostasi
mucos
induct
site
gener
dissemin
compartment
secretori
immun
respons
gener
immun
respons
mucosa
surfac
mani
signific
infect
begin
readili
aclhev
corfventiona
rout
parentera
inject
thougb
ii
usua
ly
effect
e
icit
circu
ate
antibodi
system
cellmedi
immun
respons
contrast
mucosa
administr
antigen
may
resu
concomit
express
antibodi
respons
variou
mucosa
tissu
secret
usna
ly
without
pronounc
system
immun
respons
extens
studi
concern
origin
band
meag
ymphocyt
u
timat
popu
ate
mucosa
tissu
secretori
g
and
immun
rout
effect
induct
secretori
antibodi
respons
indic
malt
divid
two
functiona
distinct
compart
name
induct
effector
site
physiolog
divis
paramount
import
design
vaccin
effect
induct
protect
immun
within
mucos
immun
system
particular
humor
branch
experi
perform
anim
model
recent
scid
mice
engraft
human
mucos
lymphoid
cell
reveal
induct
site
present
certain
locat
peyer
patch
smal
intestin
speci
tonsi
upper
aerodigest
tract
function
primari
sourc
precursor
ce
migrat
ymp
iatic
b
ood
direct
extravas
popul
remot
mucos
tissu
gland
studi
ed
notion
common
mucosa
immun
system
fig
genera
iev
antigen
taken
specia
ize
epit
ie
ia
ce
cell
membran
cell
cover
mucos
induct
site
channel
parenchym
macrophag
dc
b
lymphocyt
even
mast
cell
andor
process
perhap
present
directli
epitheli
cell
underli
b
ce
fo
owe
interact
antigen
accessori
ce
cognat
helper
ce
andor
b
lympiiocyt
iocai
iymphoid
microenviron
immun
respons
may
ensu
major
antigen
tiii
result
presumahli
suppress
specif
immun
mucosai
toieranc
see
beiow
howev
deveiop
activ
immun
respons
may
also
foiiow
mucos
intak
atitigen
characterist
immun
respons
gener
inciud
tiie
baianc
hetween
activ
immun
suppressiontoier
may
influenc
sever
factor
inciud
natur
ofth
antigen
type
accessori
ceii
cytokin
iymphocyt
invoiv
atid
genet
background
host
two
major
type
activ
immun
respons
may
deveiop
either
concomitantiy
separateiy
antibodi
format
mainiy
siga
ceiiniedi
immun
sensit
immunocyt
particuiar
antigensensit
b
cell
presumahli
aiso
ceii
leav
site
initi
encount
antigen
eg
peyer
patch
transit
thorac
duct
enter
circuiat
seed
mucosa
distant
yet
priviieg
mucosai
site
tiieir
new
iocat
tiie
commit
b
ceii
may
differenti
piasma
ceii
produc
antihodi
mainiy
dimer
iga
infiuenc
iocal
produc
cytokin
iga
celi
cyci
first
eiucid
animai
tiirough
adopt
transfer
ceii
gutand
hronchusassoci
iymphoid
tissu
galt
balt
recipi
whose
mucosai
tissu
giand
popuiat
hy
iga
piasma
ceii
donor
origin
importantiy
vaccin
deveiop
evid
exist
ofa
common
mucosai
imtnun
system
human
strengthen
recent
year
severai
studi
addit
detect
specif
siga
antibodi
remot
secret
induc
natur
exposur
antigen
orai
immun
anaiys
igasecrec
ceii
peripher
biood
mucosai
tissu
enter
immun
provid
strong
support
concept
system
find
may
explain
unif
humor
immun
respons
divers
mucos
site
physiolog
segreg
mucos
nonmucos
immun
mechan
base
concept
common
mucos
immun
system
fraction
lymphocyt
activ
gut
eg
hy
iugest
antigen
dissemin
immun
intestin
hut
also
mucos
glandular
tissu
current
inuch
interest
possibl
develop
oral
vaccin
enter
nonenter
tnucos
infect
eg
respiratori
genit
tract
howev
recent
studi
involv
immun
human
nonhuman
primat
well
rodent
prototyp
nonrepl
immunogen
cholera
toxoid
cholera
toxin
indic
substanti
degre
subcompartment
exist
within
mucos
immun
system
even
within
given
mucos
organ
gut
regard
home
iga
plasma
cell
precursor
final
redistrihut
progenitor
malt
compris
anatom
defin
lymphoid
microcompart
peyer
patch
small
intestin
appendix
solitari
follicl
larg
intestin
rectum
nasal
mucosa
tonsil
entranc
ofth
aerodigest
tract
serv
princip
mucos
induct
site
immun
respons
he
initi
also
contain
diffus
accumul
larg
number
lymphoid
cell
associ
appar
organ
structur
cell
either
distribut
lamina
propria
interspers
among
epitheli
cell
mucos
tissu
gland
form
mucos
effector
site
immun
respons
express
gut
mucosa
particularli
well
invest
diffus
lymphoid
tissu
import
vaccin
develop
fact
immun
certain
induct
site
may
give
rise
humor
immun
respons
preferenti
manifest
certain
effector
site
thu
given
induct
site
may
serv
preferenti
exclus
sourc
precursor
cell
certain
mucos
tissu
lmmunoio
kfll
review
induct
site
gutassoci
lymphoid
tissu
galt
gut
contain
tbe
abund
ymphoid
tissu
inc
ude
organ
diffus
lymphoid
e
ement
organ
ymphoid
tissu
compris
two
unit
bce
follic
es
paraor
interfo
hcu
ar
tce
area
assemb
ed
within
matrix
oos
connect
tissu
fo
licular
dc
fouic
es
occur
sing
group
harbour
variab
e
number
macrophag
ce
fo
ic
edom
structur
form
main
ymphoid
compon
peyer
patch
jejunum
eum
found
arg
intestin
especia
appendix
structur
appear
p
ay
import
ro
e
induct
dissemin
immun
respons
ora
vaccin
fig
typica
fo
ic
es
contain
major
b
ce
approxim
half
activ
tcel
zone
compris
major
ce
ap
tcr
cell
main
locat
parafo
licular
area
wherea
ys
tcr
cell
rare
dome
cover
specia
ize
epit
ie
ium
fo
ic
eassoci
epich
ium
fae
contain
antigentransport
ce
ceca
co
onic
mucosa
variabl
invest
comparab
e
ymp
ioid
patch
although
epithehum
cover
ies
ymphoid
aggreg
show
specia
izat
mce
contain
fae
c
uster
fo
lic
es
found
adjac
anorecta
junction
ie
potentia
import
recta
ymphoid
tissu
iga
induct
site
sourc
iga
plasma
ce
precursor
suggest
sever
studi
first
predomin
ceu
igal
cell
lamina
propria
arg
intestin
c
ear
diverg
ativ
apport
two
mucosa
tissu
smal
intestin
upper
arg
intestin
fnrt
ier
recta
immun
human
nonhuman
primat
rodent
shown
induc
strong
secretori
antibodi
respons
recta
miicosa
although
instanc
rectal
immun
induc
secretori
antibodi
respons
therect
mucosa
instanc
rectal
vaccin
con
induc
specif
antibodi
serum
secret
remot
mucosa
organ
sa
iva
genita
secret
though
potentia
recta
mucosa
serv
site
induct
mucos
respons
wel
estab
ish
shou
point
tbat
rectal
immun
macaqu
wit
ct
one
ie
powerfu
mucosa
immunogen
shown
poor
effect
induc
immun
respons
upper
part
intestin
especia
smai
intestin
recent
new
type
organ
lymphoid
tissu
term
cryptopatch
identifi
murin
intestin
consist
microscop
aggreg
fewhundr
ceu
immatur
ymphocyt
c
uster
die
amina
propria
although
cryptopatch
yet
identifi
human
propos
repres
precursor
sourc
intestin
intraepitheh
ce
potentia
ro
e
structur
induct
activ
immun
eranc
mucosauy
encount
antigen
remain
exp
ore
induct
site
nasopharyng
lymphoreticular
tissu
nalt
severa
recent
studi
emp
iasiz
import
nasa
caviti
gener
mucos
system
immun
respons
may
exceed
magnitud
induc
ora
immun
introduc
nasa
caviti
usua
ong
mucosa
adjuv
vira
bacteria
antigen
induc
superior
immun
respons
externa
secret
sa
iva
surpris
ill
fema
e
genit
tract
secret
neither
igg
iga
antibodi
titer
vagina
wash
corr
ate
serum
antibodi
respons
assum
antibodi
isotyp
predominantli
mucosa
origin
find
may
import
imp
icat
design
vaccin
effect
induct
immun
respons
genit
tract
tbu
differ
immun
rout
intranas
oral
induc
genera
ize
mucosa
immun
respons
although
rel
represent
domin
antibodi
isotyp
may
vari
neverth
ess
nasa
immun
appear
induc
siga
immun
broader
rang
mucosa
tissu
ian
ora
vaccin
may
exp
ain
recent
observ
circul
igasecret
ce
induc
nasal
vaccin
express
promiscu
profi
e
home
receptor
ieir
correspond
counterpart
rais
ora
recta
immun
whether
antibodi
respons
induc
e
genita
tract
remain
determin
immunohistochemica
studi
indic
epith
ium
human
nasa
mucosa
contain
intraepith
ia
ymphocyt
ifl
stain
predominantli
ack
home
receptor
analogu
pew
nasal
iel
stain
nasal
ifl
rare
express
hmll
wherea
ie
major
intestina
tonsi
ar
adenoid
iel
hmll
hladr
intraepitheli
dc
cell
identifi
nasa
mucosa
specimen
virtuauy
b
ce
organ
subepithelia
lympboid
tissu
found
norma
human
nasa
mucosa
contrast
nasa
mucosa
adu
rat
mice
compris
ymp
ioid
structur
witb
distinct
tand
bce
area
furtbermor
major
intraepitheha
ymphocyt
popul
nasal
epithelium
slg
b
cell
cdb
cell
rat
wherea
murin
nasal
epithelium
infiltr
mainli
lymphocyt
b
cell
thu
human
nasal
mucosa
seem
differ
rodent
commonli
use
anim
preclin
vaccin
studi
also
endcjdermaili
deriv
hunian
mucosa
tonsil
adenoid
latter
lymphoid
structur
appear
major
thu
within
context
ofth
common
mucos
immun
system
certain
organ
may
favor
develop
igacommit
precursor
b
cell
whose
progeni
preferenti
destin
particular
mucos
locat
new
knowledg
call
sitedirect
vaccin
strategi
sinc
jenner
introduc
vaccin
year
ago
fewer
vaccin
approv
human
use
nearli
half
improv
version
earher
form
five
current
vaccin
oral
poliovaccin
oral
kill
whole
subunit
cholera
vaccin
oral
salmondia
typhi
vaccin
oral
rotaviru
vaccin
nasal
liveattenu
influenza
viru
vaccin
complet
phase
iii
clinic
test
administ
parenter
provid
signific
mucos
immun
almost
axiomat
order
efficacioti
vaccin
mucosai
infect
must
stimuiat
malt
atid
goai
usual
better
achiev
administ
immunogen
mucos
rout
rather
parenteraiiy
howev
even
stimul
secretori
immun
respons
mucosai
administr
nonrepi
antigen
often
reiativeiy
ineffici
requir
niuitipi
administr
iarg
quantiti
immunogen
yieid
often
toieranc
ali
modest
immun
respons
tiii
conclus
pliysiolog
justifiabi
sinc
primari
function
tile
mucosai
immun
system
prevent
overstimuiatioti
ofth
entir
immun
system
elimin
mucosaiiy
appii
antigen
witii
denatur
acid
degrad
enzym
otiier
innat
factor
weii
intestinai
peristalsi
ciliari
movement
epithelia
respiratori
tract
tiii
baciiground
mucosai
vaccinoiogist
eiabor
numer
deiiveri
system
adjuv
partli
circumv
naturai
obstaci
evergrow
list
mucosai
deiiveri
system
describ
tlie
iiteratur
bear
wit
difficu
encount
hmite
practic
usefui
deiiveri
devic
wiii
therefor
concentr
promis
system
furthermor
shouid
emphas
resuit
heen
obtain
animai
modei
rather
human
ali
unavoidahi
iimit
inert
vaccin
deliveri
system
antigen
immunogen
particui
form
soiution
hecaus
vuinerabi
antigendegrad
enzym
acid
tiiey
often
heen
incorpor
vehicl
themseiv
nontox
nonimmunogen
whicii
protect
vaccin
materiai
degrad
enhanc
tiieir
uptak
fr
dm
mucosai
surfac
may
exhihit
adjuv
effect
geiatin
capsui
coat
suhstanc
e
g
ceiiuios
acet
phthaiat
dissoiv
alkaiin
ph
intestin
acid
ph
stomach
use
orai
dehveri
bacteriai
virai
vaccin
severai
studi
perform
human
tiieir
use
never
systematicaliy
assess
avoid
fast
passag
free
antigen
mucoadhes
polym
adher
mucos
surfac
thu
extend
time
exposur
vaccin
use
severai
recent
studi
compound
suchashighiy
viscou
inert
poiysaccharid
eldexom
carboxymethyl
ceiiuios
use
antigen
infiuenza
viru
ctb
oral
intranasaliy
intravaginaiiy
administ
botii
iocai
mucos
system
immun
respons
induc
compound
heen
consid
carhapol
poiycarbopiii
sodium
algiiiat
hydroxypropyl
cellulos
use
medicin
drug
deliveri
liposom
use
mucos
vaccin
studi
bacteri
viral
antigen
iiav
administ
oraiiy
intranasaiiy
rodent
monisey
human
result
induct
mucosai
system
immun
respons
review
relat
antigen
deliveri
system
cochieat
compos
proteinphosphoiipidcaicium
precipit
entrap
antigen
heen
use
mucosai
deiiveri
giycoprotein
peptid
influenza
viru
siv
iiposom
humor
weii
ceiimedi
immun
cmi
induc
wiien
given
tiie
oral
rout
biodegradabi
microspiier
compos
antigen
incorpor
poiymer
iactic
giycoiic
acid
iiav
use
far
extens
mucosai
vaccinoiogi
inert
deiiveri
system
microspher
gain
popular
hecaus
stabil
whicli
allow
protect
incorpor
antigen
acid
enzym
eas
wiiich
size
rate
biodegrad
modifi
microspher
themseiv
nonantigen
easiiy
reus
offer
advantag
live
vector
rate
releas
antigen
theoret
controii
mix
fastand
siowreleas
microspher
aliow
induct
combin
primari
secondari
immun
respons
singi
immun
finaiiy
wouid
seem
possibi
incorpor
immunoreguiatori
cytoicin
dna
encod
differ
antigen
aciiiev
desir
immun
resp
attempt
progress
obviou
attract
featur
tlie
inert
deliveri
system
counterbaianc
seriou
disadvantag
specificaiiy
disappointingli
low
absorpt
rate
usuaiiy
much
iess
tiian
ingest
dose
render
procedur
expens
moreov
use
organ
solvent
incorpor
antigen
may
severeiy
compromis
immunogen
sucii
vaccin
howev
attempt
he
made
increas
ahsorpt
rate
deveiop
condit
incorpor
minim
degrad
antigen
mucos
iectinlik
molecul
carrierdeliveri
system
oral
administr
small
amount
protein
antigen
coval
coupl
carrier
moiecui
known
affin
mucos
epitheli
cell
ct
escherichia
coii
heatlabil
toxin
lt
ctb
ltb
eucit
mucos
also
certain
condit
system
antibodi
respons
conjug
antigen
strategi
also
recent
util
induc
mucosa
immun
respons
carbohydr
antigen
fusion
protein
creat
hybrid
ctb
ltb
gene
encod
ietero
ogou
antigen
gener
prefer
chemicauy
coupl
protein
free
contamin
ho
otoxin
uniform
structur
overexpress
system
develop
facilit
argescal
prodttction
fusion
protein
other
creat
fusion
antigen
mutant
lac
toxic
al
subtmit
interestingli
though
oral
administr
induc
serum
igg
antihodi
maximttm
niuccjsal
iga
respons
requir
addit
ie
e
ct
thu
appear
ctb
exc
ent
carrier
mo
ecu
e
due
abil
bind
gml
receptor
epitheli
cell
best
exhibit
low
adjuv
properti
live
recombin
microorgan
mucos
deliveri
stem
long
assum
ive
vaccin
wotdd
effici
stimu
ate
tnucosa
immun
respons
sinc
major
microbi
pathogen
co
oniz
enter
irough
mucosa
surfac
henc
evolv
strategi
circumv
natura
physicochemica
barrier
furt
iermor
natura
infect
abil
vector
co
oniz
specif
mucosa
oca
es
gener
immun
respons
desir
site
import
factor
determin
suitabihti
vaccin
vebic
e
import
factor
consid
abi
iti
given
intranasa
immun
emerg
perhap
effect
rout
induct
periphera
mucosa
immim
vaccin
usefu
ness
mycobacterium
bovi
strain
baci
e
ca
mett
guerin
bcg
deliveri
system
recombin
antigen
document
severa
mode
specirica
bcgvector
outer
surfac
protein
pneumococca
protein
confer
protect
borrelia
pnetimonia
respect
given
nasa
mice
review
recent
attenu
bordetella
pertasi
strain
construct
delet
pertussi
toxin
gene
use
ive
vector
intranasa
de
iveri
hetero
ogou
antigen
express
tlie
surfac
b
perttisd
via
fusion
fi
ament
heinagg
utinin
vra
gene
intranas
deliveri
immunolog
rmeiv
b
pertussi
express
parasit
antigen
fuse
fha
induc
strong
mucosa
immun
respons
ativ
modest
serum
antibodi
respons
fuse
antigen
nevert
ie
ess
approach
cou
use
construct
combin
vaccin
protect
whoop
cough
otlier
respiratori
infect
adenovirus
rad
proven
rather
attract
system
tissu
target
de
iveri
mamma
ian
microbia
gene
gene
therapi
vaccino
ogi
respect
mva
hold
promis
safe
effect
mucosa
vaccin
de
iveri
system
genera
suc
nonrep
ic
poxvira
vector
promis
mucosa
deliveri
system
use
rna
virus
vector
initia
ag
behind
use
dna
virus
main
due
ativ
eas
manipu
ate
dna
genom
given
progress
recombin
dna
techno
ogi
deve
opment
rna
virus
immunoiog
reiim
cine
vector
caught
dna
virus
review
recombin
vaccin
strategi
use
rna
virus
polioviru
alphavirus
venezuelan
equin
enceph
viru
vee
semliki
forest
viru
aud
paramyxovirus
rsv
vector
activ
explor
mucos
immun
particular
replicationcompet
vee
express
hiv
gag
influenza
viru
ha
gene
shown
induc
mucos
cellular
immun
respons
interestingli
replicon
vaccin
vector
system
develop
frcmi
attenu
strain
vee
replicon
rna
consist
cisact
end
vee
genom
complet
nonstructur
protein
gene
region
subgenom
promot
immun
mice
vee
replicon
express
influenza
ha
lassa
viru
n
gene
induc
ancibodi
respons
express
protein
demonstr
capabl
sequenti
immun
multipl
pathogen
host
likewis
recombiu
poiioviru
engin
replicationcompet
vector
replicon
review
uniqu
aspect
virus
includ
port
entri
point
promis
develop
mucos
vaccinoiogi
sinc
wolff
colleagu
report
direct
intramuscular
inject
mice
plasmid
dna
encod
complet
sequenc
gene
result
durabl
express
encod
protein
immun
plasmid
dna
encod
virul
gene
sever
import
pathogen
shown
induc
protect
immun
sever
preclin
studi
although
mani
issu
includ
safeti
consider
need
care
assess
approach
offer
substanti
advantag
asid
stabil
eas
product
includ
induct
immun
noninfecii
agent
aud
thu
possibl
vaccin
organ
wilh
propens
longterm
persist
bodi
eg
cytomegaloviru
hiv
furthermor
dna
immun
would
allow
select
nucleic
acid
correspond
broad
rang
polypeptid
overcom
problem
mhc
genet
restrict
outbr
popul
addit
plasmid
backbon
also
equip
harbour
sequenc
encod
cycokin
gene
faciht
type
immun
respons
desir
principl
dna
use
vaccin
plasmid
couiain
bacteri
origin
replic
aud
antibiot
resist
gene
requir
select
plasmid
product
e
coli
gene
interest
clone
contro
strong
promot
usual
viral
promot
iu
addit
express
cassett
plasmid
may
contain
immunostimulatori
sequenc
appear
critic
govern
immunogen
express
gene
sequenc
includ
nonmethyl
cpg
motif
within
palindrom
hexam
oligonucleotid
sequenc
report
induc
bceli
prolifer
thl
cycokin
product
stimulatori
properti
motif
appear
mediat
via
select
activ
dc
interest
note
mucos
administr
synthet
oligodeoxynucleocid
contain
cpg
motif
enhanc
viru
specif
respons
suggest
nucleotid
could
use
also
mucos
adjuv
although
major
studi
far
dealt
incracutan
intramuscular
administr
dna
vaccin
approach
gain
popular
among
mucos
vaccinoiogist
nake
plasmid
dna
directli
use
mucos
immun
thu
intranas
iutratrach
administr
ofa
dna
plasmid
enccjd
influenza
viru
hemaggiutinin
induc
protect
lethal
influenza
viru
challeng
mice
recent
intranas
immunizacion
mice
dna
plasmid
encod
iacz
herp
simplex
viru
type
glycoprotein
b
gb
induc
lacz
gb
express
lung
cervic
lymph
node
although
distal
mucos
iga
respons
antihsv
cellmedi
immun
respons
observ
follow
three
n
administr
gb
dna
protect
lethal
vagin
hsv
challeng
lower
seen
intramuscular
administr
plasmid
intrabucc
inject
nasal
administr
plasmid
dna
encod
measl
viru
hemaggiutinin
induc
system
mhc
class
irestrict
ctl
respons
intravagin
instil
ofa
plasmid
dna
encod
envelop
glycoprotein
elicit
product
iga
igg
antibodi
vagin
fluid
serum
neutral
antibodi
construct
employ
demonstr
plasmid
dna
vaccin
infant
chimpanze
well
toler
could
induc
serum
antibodi
convent
vaccin
sever
formul
develop
faciiit
uptak
plasmid
dnabas
vacciu
protect
chem
degrad
mucos
microenviron
use
liposom
cation
lipid
monophosphoryl
lipid
mucosa
deliveri
dna
shown
increas
express
immunogeu
ofth
correspond
protein
suggest
thac
lipid
matrix
may
also
provid
secondari
role
adjuvanc
facilit
dna
uptak
apc
promot
local
inflamm
iu
che
case
oral
deliveri
plasmid
dna
also
protect
degrad
che
guc
encapsulacion
immunolog
review
poiy
dliactidecoglycohd
pgl
microparticl
attenu
intraceliular
bacteria
sucb
salmoneiia
wbicb
retain
within
vacuoi
tbe
infect
ceii
iiav
recentiy
shown
promis
tile
dehveri
plasmid
dna
thu
infect
periton
macrophag
lyphi
carri
plasmid
encod
lac
z
resuit
transfer
piasmid
dna
tbe
infect
ceii
recentiy
approach
employ
demonstr
tbat
orai
administr
typhi
carri
tumor
antigen
resuit
gene
transfer
host
dc
protect
mice
fibrosarcoma
mechan
underli
tbe
induct
immun
respons
mucos
dna
vaccin
stiii
unknown
hkeli
analog
involv
system
intramuscular
intradermai
dna
administr
transfer
antigen
tissuetransfect
epitheiiai
cell
professionai
mucos
apc
crossprim
direct
transfect
profession
apc
especiaiiy
dc
mucosai
vaccin
wouid
wideiy
use
especiaiiy
develop
countri
couid
produc
lower
cost
distribut
without
refriger
concept
vaccin
product
transgen
plant
introduc
recentiy
base
premis
plant
capac
produc
abund
biomass
recombin
immunogen
could
produc
plant
tissu
sinc
plant
engin
contain
muhipl
foreign
gene
multicompon
transgen
plant
vaccin
therefor
feasibl
severai
piant
express
system
eg
potato
tobacco
plant
develop
sbown
aiiow
express
microbiai
antigen
hepat
b
surfac
antigen
e
coli
ltb
even
norwalk
viruslik
particl
vlp
review
although
ievei
express
recombinanl
antigen
bave
far
disappoint
feed
animai
potato
tuber
express
norwalk
vlp
e
coli
ltb
induc
specif
secretori
iga
antibodi
respons
serum
igg
respons
transgen
protein
develop
strategi
lo
increas
antigen
express
edibi
plant
inciud
tbe
use
strong
tissuespecif
promot
remain
one
import
ciialleng
tiii
area
vaccin
deveiop
dc
potent
apg
piay
centrai
roie
induct
immun
initi
immunomodui
immun
respons
owe
capac
prime
ceii
dc
ioad
ex
vivo
tumor
antigen
extensiveiy
use
potentiai
cancer
vaccin
given
promis
preciin
resuit
studi
underway
patient
adopt
transfer
dc
puls
ex
vivo
infecti
microorgan
could
constitut
way
induc
broadbas
immun
infecti
diseas
lia
also
document
date
potenti
dc
vaccin
carrier
induct
mucos
respons
largeiy
unknown
respect
recent
studi
shown
dc
puis
ex
vivo
kiil
ciiiamydia
subsequ
transfer
naiv
recipi
abi
induc
protect
thl
immun
respons
genitai
chaiieng
cblamydia
altbough
studi
use
bone
marrowderiv
dc
first
one
document
tbe
efficaci
approach
mucosai
infect
introduct
protein
inciud
vaccin
mucos
induct
site
effect
way
induc
system
unrespons
mucosai
toler
thu
mucos
adjuv
requir
boost
mucosai
system
immun
aiso
prevent
induct
mucosai
toler
although
varieti
compound
report
display
adjuv
properti
mucosaliy
coadminist
antigen
power
henc
studi
mucosai
adjuv
tlie
vibrio
ciiolera
exotoxin
ct
structurai
bioiogicai
anaiog
lt
tbese
macromolecui
compos
two
structuraiiy
functionaiiy
immunologicaliy
separ
b
subunit
b
subunit
botii
toxin
consist
five
identicai
monom
pentamer
b
subunit
gt
ctb
bind
oniy
gml
gangliosid
tbe
b
subunit
pentam
lt
ltb
promiscu
bind
gml
weil
asiaio
gml
giycoprotein
receptor
b
subunit
bind
epitbeii
ceil
gml
receptor
subunit
reach
cytosoi
bind
nad
cataiyz
adpribosyi
gsa
gtpbind
protein
activ
adenyi
cycias
witii
subsequ
eievat
camp
whicb
epitheli
celi
result
secret
water
chlorid
ion
small
intestin
mucos
exposur
ct
lt
whicii
botii
immunogen
resuit
siga
serum
igg
antibodi
wiiich
aimost
entir
restrict
ctb
ltb
importantiy
botb
toxin
potent
mucos
adjuv
unrel
protein
coadniinist
orai
intranas
even
parenterai
rout
recent
studi
suggest
orai
nasal
immun
protein
aiong
gt
adjuv
induc
respons
intestin
mucosa
immun
protocol
induc
cell
peyer
patch
spleen
well
higb
iggl
ige
respons
absenc
detect
titer
oral
immun
keyhol
iimpet
hemocyanin
klh
ct
mix
ctb
result
peyer
patch
iamina
propria
tiymphocyt
popuiat
whicii
produc
iow
ifnybut
higii
ievei
howev
otber
studi
showii
tbat
oral
coadministr
soiubi
particui
antigen
ct
prime
anim
system
thltype
immun
respons
delayedtyp
bypersensit
induc
function
gtl
spieen
resuit
studi
suggest
orai
immun
heteroiog
antigen
ct
adjuv
differentiaiiy
affect
mucos
system
immun
respons
induc
immtm
respons
mucos
tissu
aud
well
thllype
respons
system
compart
tbu
natur
adjuv
also
tiiat
tbe
antigen
use
mucos
rout
deliveri
ail
influenc
wbether
tblandor
respons
develop
ct
lt
caus
sever
diarrhea
iiuman
account
tiie
clinic
manifest
choiera
enterotoxigen
e
coli
enter
tbu
neither
suitabl
use
enter
adjuv
human
earli
studi
attempt
faii
dissoci
diarrhoeagen
tbe
adjuvani
two
moiecui
exampi
nontox
mutant
form
make
singi
amino
acid
substitut
tbe
adp
ribosyitransferas
activ
center
also
lack
adjuvant
administ
oraliy
howev
mutant
lt
form
substitut
singl
amino
acid
eitiier
outsid
adpribosyitransferas
cieft
retain
adjuvant
despit
appar
iack
toxic
wben
administ
intranasai
rout
moreov
two
mutant
gt
harbor
singl
amino
acid
substitut
adpribosyltranferas
activ
center
complet
iack
adpribosyitransferas
activ
diarrheageniciiy
remain
effect
adjuv
comparabi
nativ
ct
wben
given
parenteraiiy
nasaiiy
found
recombin
ctb
ltb
aiso
moderateiy
adjuv
coadminist
otber
protein
antigen
tile
nasai
rout
tiie
orai
rout
c
czerkinski
j
hoimgren
unpublish
observ
sinc
enterotox
tbe
main
obstacl
use
nativ
ct
lt
oral
adjuv
interest
determin
whether
enzymat
inact
ct
lt
mutant
retain
adjuv
activ
given
oral
one
tiie
primari
goai
develop
effect
therapi
diseas
caus
unwant
tissu
damag
inflammatori
immun
respons
specificaiiy
suppress
decreas
acceptabi
level
tbe
intens
untoward
immun
reaction
witbout
affect
remaind
immun
system
induct
toler
matur
pathogen
celi
repres
ideai
form
specif
immunotberapi
treatment
chronic
inflammatori
autoimmun
disord
allergi
three
main
mode
peripiierai
toieranc
induct
antigen
consid
parenterai
administr
antigen
parenter
administr
antigen
analog
whicii
act
tceii
receptor
antagonist
mucosai
administr
antigen
socail
orai
toieranc
mucos
administr
antigen
fact
iongrecogn
method
induc
peripherai
toieranc
piienomenon
often
refer
oral
toler
initi
document
effect
oral
administr
antigen
character
fact
anim
fed
inbai
antigen
becom
refractori
diminish
capabii
deveiop
immun
respons
reexpos
antigen
introduc
tbe
system
rout
eg
inject
tbi
effect
especiaiiy
pronounc
thl
ceiimedi
immun
respons
regard
import
naturai
physioiogicai
mechan
wherebi
avoid
deveiop
deiayedtyp
iiypersensit
reaction
dietari
airborn
antigen
product
commens
microorgan
mucosaliy
induc
immunoiogicai
toler
affect
ail
type
adapt
immun
respons
depend
tbe
anim
speci
age
form
dose
antigen
rout
mucosai
administr
enter
buccal
nasal
rectai
genitai
mechan
toler
mucos
deliveri
antigen
mucosai
uptak
antigen
may
resuit
deveiop
immun
toler
even
botii
decis
taken
epithelium
underiy
iymphoid
tissu
mainli
determin
tiie
natur
physicochemicai
form
antigen
depend
upon
tbe
dose
antigen
administ
deietion
anergi
antigenspecif
cell
andor
expans
cell
produc
immunosuppress
cytokin
tgpp
review
may
result
decreas
tcell
respons
interest
note
tbe
latter
scenario
involv
cytokin
tbat
also
known
promot
iga
isotyp
switcb
iga
product
thu
compat
tlie
observ
tbat
secretori
iga
antibodi
respons
system
tceii
toler
may
develop
concomitantli
toieranc
transfer
serum
cell
toler
animai
possibl
tbat
bumorai
antibodi
iga
circul
undegrad
antigen
toierogen
fragment
cytokin
may
act
synergist
confer
tceli
unrespons
without
exciudiiig
possibii
anoth
mechan
may
consid
could
involv
antigendriven
attract
infiammatori
ceii
peripheri
mucosai
microenviron
could
render
anerg
functionaiiy
skew
deiet
even
ignor
tbi
form
antigendriven
anatom
deviat
wouid
impli
inflammatori
celi
activ
peripher
tissu
exhibit
promiscu
migratori
behaviour
aiiow
entri
system
organ
aiso
mucosai
tissu
tbe
site
antigen
uptak
tbe
latter
scenario
yet
address
experimentaiiy
compat
witb
studi
sbow
tiiat
arthritogen
diabetogen
celi
express
tiie
cell
surfac
mucos
integrin
whose
hgand
mucos
addressiii
ceiiuiar
adbes
moiecui
madcaml
also
express
inflam
pancrea
synovi
tissu
respect
aiso
interest
lo
note
oral
toler
prototyp
soiubi
protein
antigen
iia
recentiy
shown
differentiaiiy
affect
product
peripherai
cell
tiie
li
cc
chemokin
mlpla
wbich
potent
chemoattract
celi
irrespect
effector
mechan
invoiv
major
question
aris
bow
toieranc
induc
suppress
anergi
delet
ignor
andor
anatomicai
deviat
date
httie
known
regard
mechan
govern
induct
mucos
toler
especi
intraceliular
pathway
entri
tolerogen
tbe
natur
apc
eiement
invoiv
tiieir
tissu
iocahz
tbe
characterist
signai
transduc
ceii
respond
ceii
varianc
systemicaiiy
administ
antigen
antigen
fiandl
mucosai
tissu
bave
aireadi
subject
varieti
innat
factor
sucb
e
g
proteas
acid
sait
mucin
aiter
form
prior
uptak
resuit
tbi
extratissuiar
condit
differ
epitop
may
expos
uptak
andor
process
may
involv
mani
differ
ceii
type
observ
thac
mucos
induc
system
toieranc
depend
intact
epitheiiai
barrier
suggest
centrai
roie
epitheiium
ceii
shown
uptak
varieti
particui
antigen
virus
bacteria
aiiow
direct
entri
invas
microorgan
mucos
induct
site
patbway
thought
result
induct
secretori
iga
immun
respons
aithough
tiie
abiiiti
ceii
serv
apc
appear
pooriy
support
ceii
could
still
theoret
involv
abort
form
antigen
present
iead
toieranc
induct
roie
absorpt
epitbeiiai
ceii
intestinai
enterocyt
toieranc
induct
underscor
severai
studi
review
epitheiiai
enterocyt
express
costimuiatori
moiecui
nonciassicai
mhc
ciass
cd
moiecui
involv
antigen
present
subpopul
celi
abnormai
form
ievei
mhc
ciass
ii
molecul
iead
seiectiv
trigger
suppress
cell
andor
abort
present
celi
addit
epitbeiiai
enterocyt
bave
aiso
shown
produc
cytokin
tgfp
particuiariy
effici
suppress
induct
phase
tceilmedi
respons
aii
known
type
ciassicai
apc
inciud
dc
macrophag
b
cell
even
mast
celi
sbown
popul
mucosai
tissu
beterogen
tbe
difficu
isoiat
pure
subpopul
apg
mticosai
tissu
respect
roie
induc
toieranc
yet
elucid
aithough
activ
b
ceii
tissu
macrophag
power
apc
memori
tb
ceii
evid
suggest
tbat
antigen
present
rest
b
ceii
result
tceli
toler
shouid
bowev
note
b
ceii
activ
vitro
bacteriai
iipopoiysaccharid
lp
promin
compon
normal
mucos
microflora
capabl
induc
toieranc
wiien
inject
naiv
host
aithougb
function
dc
identifi
mucos
tissu
sucb
tbe
peyer
patch
tbe
mesenter
lymph
intestin
iamina
propria
airway
mucosa
review
tiieir
roie
activ
rather
suppress
naiv
cell
receiv
strongest
support
thu
dc
freshli
isol
airway
mucosa
preferenti
activ
ceii
also
matur
apg
capabi
activ
till
thu
airway
dg
cell
could
play
pivotai
role
crossregul
thland
respons
howev
recent
experi
splenic
dendrit
ceil
siiown
differentiai
capac
dc
subpopui
activ
ceii
suggest
exist
regulatori
immunostimulatori
dc
subset
support
emerg
concept
toierogen
dc
treatment
f
ligand
known
expand
dc
vivo
ba
report
enhanc
oral
toler
interestingli
lp
whicb
known
caus
rapid
exit
dc
also
shown
eniianc
toler
induct
tbi
inform
place
strong
emphasi
tbe
site
entri
intraceiiuiar
patiiway
process
antigen
administ
mucou
membran
induct
toler
andor
immun
caii
need
deveiop
vaccin
formuia
strike
observ
aii
three
modei
autoimmun
diseas
test
fmding
treatment
ctbaiitigen
suppress
ieukocyt
infiitr
tbe
target
organ
tbi
suggest
mechan
govern
induct
toieranc
feed
inhal
ctbiink
antigen
may
involv
modif
tiie
migratori
beiiavior
infiammatori
celi
coupl
thymoeyt
cboiera
b
subunit
feed
conjug
mice
possibi
significantiy
prolong
press
botb
system
tbiand
respons
fact
type
regimen
aiso
known
favor
siga
respons
mucos
tissu
make
concept
even
attract
sinc
iga
known
nonphiogist
couid
theoreticaiiy
outcompet
igf
bind
given
aiiergen
howev
shouid
aiso
point
tbat
suppress
respons
ige
antibodi
respons
appear
considerabiy
difficult
achiev
correspond
thi
respons
eg
dth
animai
aireadi
systemicaiiy
sensit
tiie
aiiergen
iatter
situat
mucosai
treatment
ctbcon
jug
ate
aiiergen
requir
proiong
administr
ofth
conjug
effect
certain
aiiergen
c
rask
j
holmgren
c
czerkinski
unpubhsh
observ
somewhat
surprisingiy
vaccinoiogist
gener
mucosai
immunoiogist
particular
usual
believ
reciproc
relationship
exist
induct
immun
toler
tbe
observ
tiiat
mucos
immun
whicb
typifi
secretori
iga
antibodi
may
deveiop
concomitantiy
system
immunoiogicai
toieranc
iia
i
liie
behef
vaccin
mucosai
pathogen
shouid
primariiy
stimuiat
immun
without
induc
toieranc
howev
theoret
standpoint
tbe
possibihti
manipui
mucosai
immun
system
toward
botb
immun
toieranc
appear
rather
attract
wben
consid
strategi
aim
protect
host
coioniz
invas
mucosai
pathogen
aiso
interfer
witb
develop
potentiaiiy
harmfui
system
immunoiogicai
reaction
pathogen
tiieir
product
tbe
notion
tbat
immunoiogicai
toieranc
may
provid
iiost
protect
mechan
infecti
diseas
activeiy
address
mucosaiiy
induc
toieranc
ba
virtu
powerfui
naturai
specif
protect
mecban
advers
immun
reaction
tbat
may
resuit
mucosai
intak
immunogen
matter
properti
may
utiiiz
treat
disord
associ
witii
untoward
immun
respons
seif
nonseif
antigen
sucb
certain
autoimmun
diseas
aiiergic
reaction
graft
reject
tabl
